Four classes of meds linked with bullous pemphigoid

Medication-induced disease might explain rising incidence, researchers suggest

Anticholinergics, dopaminergic drugs, DPP-4 inhibitors and aldosterone antagonists might each play a role in the development of bullous pemphigoid, according to the first meta-analysis on the subject.